Crinetics Pharmaceuticals (CRNX) Non Operating Investment Income (2022 - 2024)
Crinetics Pharmaceuticals' (CRNX) quarterly Non Operating Investment Income came in at -$470000.0 in Q1 2024, up 88.81% quarter-over-quarter from -$4.2 million in Q4 2023.
Crinetics Pharmaceuticals (CRNX) Non Operating Investment Income (2022 - 2024) Analysis & Trends
Crinetics Pharmaceuticals' Non Operating Investment Income history runs 3 years deep, the most recent figure standing at -$470000.0 for Q1 2024.
- On a quarterly basis, Non Operating Investment Income changed N/A year-over-year to -$470000.0 in Q1 2024; TTM through Dec 2024 was -$470000.0, a 90.96% increase from a year earlier, with the FY2024 full-year figure at -$470000.0, up 90.96% from the prior year.
- Non Operating Investment Income climbed to -$470000.0 in Q1 2024 per CRNX's latest filing, from -$4.2 million in the prior quarter.
- Across five years, Non Operating Investment Income topped out at -$470000.0 in Q1 2024 and bottomed at -$4.2 million in Q4 2023.
- The 3-year median for Non Operating Investment Income is -$1.0 million (2022), against an average of -$1.7 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Crinetics Pharmaceuticals | 8.73 Bn | 7.44 Bn | 10.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -470,000.00 |
| Mar 31, 2024 | -470,000.00 |
| Dec 31, 2023 | -4.20 Mn |
| Dec 31, 2023 | -4.20 Mn |
| Sep 30, 2023 | -997,000.00 |
| Sep 30, 2023 | -997,000.00 |
| Mar 31, 2022 | -1.01 Mn |
| Mar 31, 2022 | -1.01 Mn |